- cafead   Nov 30, 2023 at 11:22: PM
via
article source
- GSK shares have lagged rivals in recent years
- Zantac litigation 'clear overhang' on stock-CEO
- Walmsley defends GSK's work on drug pipeline
- RSV vaccine data for U.S. for 50-59 year olds by year-end-CEO
article source